Cargando…
Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020611/ https://www.ncbi.nlm.nih.gov/pubmed/36937928 http://dx.doi.org/10.3389/fcvm.2023.1162630 |
| _version_ | 1784908298379591680 |
|---|---|
| author | Galli, Mattia Costa, Francesco Angiolillo, Dominick J. |
| author_facet | Galli, Mattia Costa, Francesco Angiolillo, Dominick J. |
| author_sort | Galli, Mattia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10020611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100206112023-03-18 Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions Galli, Mattia Costa, Francesco Angiolillo, Dominick J. Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2023-03-03 /pmc/articles/PMC10020611/ /pubmed/36937928 http://dx.doi.org/10.3389/fcvm.2023.1162630 Text en © 2023 Galli, Costa and Angiolillo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Galli, Mattia Costa, Francesco Angiolillo, Dominick J. Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title | Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title_full | Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title_fullStr | Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title_full_unstemmed | Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title_short | Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| title_sort | editorial: precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020611/ https://www.ncbi.nlm.nih.gov/pubmed/36937928 http://dx.doi.org/10.3389/fcvm.2023.1162630 |
| work_keys_str_mv | AT gallimattia editorialprecisionmedicineforantithrombotictherapyinpatientsafterpercutaneouscoronaryinterventions AT costafrancesco editorialprecisionmedicineforantithrombotictherapyinpatientsafterpercutaneouscoronaryinterventions AT angiolillodominickj editorialprecisionmedicineforantithrombotictherapyinpatientsafterpercutaneouscoronaryinterventions |